Ipca Laboratories has reported results for third quarter ended December 31, 2016.
The company has reported 57.22% rise in its net profit at Rs 41.38 crore for the quarter under review as compared to Rs 26.32 crore for the same quarter in the previous year. Total income of the company increased by 8.23% at Rs 756.66 crore for the quarter under review as compared to Rs 699.13 crore for the corresponding quarter previous year.
Ipca is a fully integrated Indian pharmaceutical company manufacturing over 350 formulations and 80 APIs for various therapeutic segments. For more than 60 years, Ipca has been partnering healthcare globally in over 110 countries and in markets as diverse as Africa, Asia, Australia, Europe and the US.